share_log

Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights

SEC ·  Nov 8, 2022 21:41
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.